 SAN DIEGO, Sept. 07, 2022 GLOBE NEWSWIRE -- Capricor Therapeutics NASDAQ: CAPR a biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other select diseases, announced today that the Company will present at the following upcoming investor conferences in September. 